The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: A randomised, double-blind, placebo-controlled study

Compendium of physical activities: an update of activity codes and MET intensities

AINSWORTH, B. E., HASKELL, W. L., WHITT, M. C., IRWIN, M. L., SWARTZ, A. M., STRATH, S. J., O???BRIEN, W. L., BASSETT, D. R., SCHMITZ, K. H., EMPLAINCOURT, P. O., et al. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009001-00009 · Cited by 8,497 · see citing works

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320 · see citing works

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000316 · Cited by 680 · see citing works

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475 · see citing works

High-Dose Resveratrol Supplementation in Obese Men

Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455 · see citing works

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

Eslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.068890 · Cited by 406 · see citing works

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391 · see citing works

Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

Yoshino, J., Conte, C., Fontana, L., Mittendorfer, B., Imai, S., Schechtman, K. B., Gu, C. C., Kunz, I., Fanelli, F. R., Patterson, B. W., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.015 · Cited by 381 · see citing works

GI Epidemiology: nonalcoholic fatty liver disease

Angulo, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03246.x · Cited by 370 · see citing works

Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity

Qiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367 · see citing works

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

Faghihzadeh, F., Adibi, P., Rafiei, R., & Hekmatdoost, A. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.09.005 · Cited by 345 · see citing works

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

Chachay, V., Macdonald, G. A., Martin, J. H., Whitehead, J. P., O'Moore‐Sullivan, T. M., Lee, P., Franklin, M. E., Klein, K., Taylor, P. J., Ferguson, M. L., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.024 · Cited by 291 · see citing works

Non-alcoholic fatty liver disease pathogenesis: The present and the future

Petta, S., Muratore, C., & Craxı̀, A. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.01.004 · Cited by 284 · see citing works

Pilot study of resveratrol in older adults with impaired glucose tolerance

Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281 · see citing works

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274 · see citing works

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

Thirunavukkarasu, M., Penumathsa, S. V., Koneru, S., Juhász, B., Zhan, L., Otani, H., Bagchi, D., Das, D. K., & Maulik, N. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.004 · Cited by 271 · see citing works

Resveratrol inhibits nonalcoholic fatty liver disease in rats

Bujanda, L., Hijona, E., Larzábal, M., Beraza, M., Aldazábal, P., García‐Urkía, N., Sarasqueta, C., Cosme, Á., Irastorza, B., González, A., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-40 · Cited by 224 · see citing works

Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?

Yilmaz, Y. N. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12046 · Cited by 217 · see citing works

Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

Bo, S., Ciccone, G., Castiglione, A., Gambino, R., Michieli, F. D., Villois, P., Durazzo, M., Cavallo‐Perin, P., & Cassader, M. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320100009 · Cited by 209 · see citing works

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

Gómez‐Zorita, S., Fernández‐Quintela, A., Macarulla, M. T., Aguirre, L., Hijona, E., Bujanda, L., Milagro, F. I., Martínez, J. A., & Portillo, M. P. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002753 · Cited by 164 · see citing works

Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients

Askari, F., Rashidkhani, B., & Hekmatdoost, A. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.11.005 · Cited by 164 · see citing works

Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation

Yang, S. J., & Lim, Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.003 · Cited by 141 · see citing works

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease

Li, L., Jie, H., Li, Z., Zhang, Y., Peng, H., Li, K., & Weng, X. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.08.036 · Cited by 134 · see citing works

Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice

Cho, S.-J., Jung, U. J., & Choi, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000347 · Cited by 130 · see citing works

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study

Eslamparast, T., Zamani, F., Hekmatdoost, A., Sharafkhah, M., Eghtesad, S., Malekzadeh, R., & Poustchi, H. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000919 · Cited by 128 · see citing works

Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease

Elias, M. C., Parise, E. R., de Carvalho, L., Szejnfeld, D., & Netto, J. P. (2009) · Nutrition · doi:10.1016/j.nut.2009.09.001 · Cited by 98 · see citing works

Nonalcoholic Fatty Liver Disease

Law, K., & Brunt, E. M. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.07.006 · Cited by 79 · see citing works

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

Ghaemi, A., Taleban, F. A., Hekmatdoost, A., Rafiei, A., Hosseini, V., Amiri, Z., Homayounfar, R., & Fakheri, H. T. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.15227 · Cited by 79 · see citing works

Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats

Xin, P., Han, H., Gao, D., Cui, W., Yang, X., Ying, C., Sun, X., & Hao, L. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.026 · Cited by 71 · see citing works

Resveratrol Improves Insulin Resistance Hyperglycemia and Hepatosteatosis But Not Hypertriglyceridemia, Inflammation, and Life Span in a Mouse Model for Werner Syndrome

Labbé, A., Garand, C., Cogger, V. C., Paquet, É. R., Desbiens, M., Couteur, D. G. L., & Lebel, M. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq184 · Cited by 71 · see citing works

Improving Glucose Metabolism With Resveratrol in a Swine Model of Metabolic Syndrome Through Alteration of Signaling Pathways in the Liver and Skeletal Muscle

Burgess, T. A. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.100 · Cited by 63 · see citing works

Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase

Choi, Y., Suh, H.-R., Yoon, Y., Lee, K. J., Kim, D. G., Kim, S., & Lee, B. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0347-z · Cited by 47 · see citing works

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy

Malekzadeh, R., & Poustchi, H. (2011) · Hepatitis Monthly · Cited by 31 · see citing works

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy.

Malekzadeh, R., & Poustchi, H. (2011) · PubMed · Cited by 31 · see citing works

Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1

Furimsky, A. M., Green, C. E., Sharp, L. E. H., Catz, P., Adjei, A. A., Parman, T., Kapetanović, I. M., Weinshilboum, R. M., & Iyer, L. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016725 · Cited by 29 · see citing works

ESPEN guideline on clinical nutrition in liver disease

Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674 · see citing works

Antioxidant effects of resveratrol in the cardiovascular system

Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 576 · see citing works

Health benefits of resveratrol: Evidence from clinical studies

Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523 · see citing works

Resveratrol and Cardiovascular Diseases

Bonnefont‐Rousselot, D. (2016) · Nutrients · doi:10.3390/nu8050250 · Cited by 447 · see citing works

ESPEN practical guideline: clinical nutrition in liver disease

Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Plauth, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.001 · Cited by 383 · see citing works

Emerging roles of SIRT1 in fatty liver diseases

Ding, R., Bao, J., & Deng, C. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19370 · Cited by 359 · see citing works

Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases

Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272 · see citing works

Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases

Gupta, S. C., Kunnumakkara, A. B., Aggarwal, S., & Aggarwal, B. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02160 · Cited by 246 · see citing works

Resveratrol, Metabolic Syndrome, and Gut Microbiota

Chaplin, A. M. L., Carpéné, C., & Mercader, J. (2018) · Nutrients · doi:10.3390/nu10111651 · Cited by 248 · see citing works

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Bagherniya, M., Nobili, V., Blesso, C. N., & Sahebkar, A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.020 · Cited by 225 · see citing works

Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: Systematic review and meta-analysis

Zhu, X., Wu, C., Qiu, S., Yuan, X., & Li, L. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0217-z · Cited by 196 · see citing works

Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities

Brown, K., Theofanous, D., Britton, R. G., Aburido, G., Pepper, C., Undru, S. S., & Howells, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020747 · Cited by 190 · see citing works

Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial

Banaszewska, B., Wrotyńska-Barczyńska, J., Spaczynski, R. Z., Pawelczyk, L., & Duleba, A. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1858 · Cited by 173 · see citing works

Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet

Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 168 · see citing works

Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study

Samsamikor, M., Daryani, N. E., Rezanejad-Asl, P., & Hekmatdoost, A. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.07.003 · Cited by 146 · see citing works

Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials

Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1422480 · Cited by 143 · see citing works

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease

Abenavoli, L., Larussa, T., Corea, A., Procopio, A. C., Boccuto, L., Dallio, M., Federico, A., & Luzza, F. (2021) · Nutrients · doi:10.3390/nu13020494 · Cited by 133 · see citing works

The Bioprotective Effects of Polyphenols on Metabolic Syndrome against Oxidative Stress: Evidences and Perspectives

Liu, K., Luo, M., & Wei, S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6713194 · Cited by 125 · see citing works

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study

Yari, Z., Rahimlou, M., Eslamparast, T., Ebrahimi-Daryani, N., Poustchi, H., & Hekmatdoost, A. (2016) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2016.1161011 · Cited by 118 · see citing works

The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications

Dal-Ros, S., & Sigrist, S. (2016) · Diseases · doi:10.3390/diseases4030024 · Cited by 112 · see citing works

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease

Saadati, S., Hatami, B., Yari, Z., Shahrbaf, M. A., Eghtesad, S., Mansour, A., Poustchi, H., Hedayati, M., Aghajanpoor-pasha, M., Sadeghi, A., et al. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0382-9 · Cited by 110 · see citing works

The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis

Javid, A. Z., Hormoznejad, R., Yousefimanesh, H. A., Zakerkish, M., Haghighizadeh, M. H., Dehghan, P., & Ravanbakhsh, M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5737 · Cited by 110 · see citing works

Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications

Zhang, S., Xu, M., Zhang, W., Liu, C., & Chen, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116110 · Cited by 102 · see citing works

Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease

Hekmatdoost, A., Shamsipour, A., Meibodi, M., Gheibizadeh, N., Eslamparast, T., & Poustchi, H. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1210101 · Cited by 98 · see citing works

Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Asghari, S., Jafarabadi, M. A., Somi, M. H., Ghavami, S.-M., & Rafraf, M. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1392264 · Cited by 92 · see citing works

The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease

Ben, M. D., Polimeni, L., Baratta, F., Pastori, D., & Angelico, F. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12899 · Cited by 88 · see citing works

Effect of resveratrol on lipid profile: An updated systematic review and meta-analysis on randomized clinical trials

Haghighatdoost, F., & Hariri, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.033 · Cited by 88 · see citing works

Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials

Charytoniuk, T., Drygalski, K., Konstantynowicz-Nowicka, K., Berk, K., & Chabowski, A. (2016) · Nutrition · doi:10.1016/j.nut.2016.09.001 · Cited by 89 · see citing works

Curcumin and Weight Loss: Does It Work?

Kasprzak‐Drozd, K., Oniszczuk, T., Gancarz, M., Kondracka, A., Rusinek, R., & Oniszczuk, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020639 · Cited by 87 · see citing works

Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis

Yang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., & Ge, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949746 · Cited by 85 · see citing works

Targeting Oxidative Stress with Polyphenols to Fight Liver Diseases

Machado, I. F., Miranda, R. G., Dorta, D. J., Rolo, A. P., & Palmeira, C. M. (2023) · Antioxidants · doi:10.3390/antiox12061212 · Cited by 85 · see citing works

Adipose tissue NAD + biology in obesity and insulin resistance: From mechanism to therapy

Yamaguchi, S., & Yoshino, J. (2017) · BioEssays · doi:10.1002/bies.201600227 · Cited by 83 · see citing works

The Roles of NRF2-Regulated Oxidative Stress and Mitochondrial Quality Control in Chronic Liver Diseases

Park, J.-S., Rustamov, N., & Roh, Y. (2023) · Antioxidants · doi:10.3390/antiox12111928 · Cited by 76 · see citing works

Bioavailability of resveratrol: Possibilities for enhancement

de Vries, K., Strydom, M. A., & Steenkamp, V. (2017) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2017.09.002 · Cited by 74 · see citing works

SIRT1: Harnessing multiple pathways to hinder NAFLD

Tian, C., Huang, R., & Xiang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107155 · Cited by 77 · see citing works

At the interface of antioxidant signalling and cellular function: Key polyphenol effects

Kerimi, A., & Williamson, G. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500940 · Cited by 71 · see citing works

New Insights on the Use of Dietary Polyphenols or Probiotics for the Management of Arterial Hypertension

Alves, J. L. D. B., de Sousa, V. P., Neto, M. P. C., Magnani, M., Braga, V. A., Costa‐Silva, J. H., Leandro, C. G., Vidal, H., & Pirola, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00448 · Cited by 71 · see citing works

Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction

Marques, B. C., Trindade, M., Aquino, J. C. F., Cunha, A. R., Gismondi, R. A., Neves, M. F., & Oigman, W. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1288741 · Cited by 67 · see citing works

Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials

Mousavi, S. M., Milajerdi, A., Sheikhi, A., Kord‐Varkaneh, H., Feinle‐Bisset, C., Larijani, B. A., & Esmaillzadeh, A. (2018) · Obesity Reviews · doi:10.1111/obr.12775 · Cited by 67 · see citing works

The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials

Huang, H., Chen, G., Liao, D., Zhu, Y., Pu, R., & Xue, X. (2016) · Obesity Reviews · doi:10.1111/obr.12458 · Cited by 66 · see citing works

Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system

Tiao, M., Lin, Y., Yu, H., Sheen, J., Lin, I.-C., Lai, Y., Tain, Y., Huang, L., & Tsai, C. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0824-3 · Cited by 65 · see citing works

Hepatoprotective effects of natural drugs: Current trends, scope, relevance and future perspectives

Datta, S., Aggarwal, D., Sehrawat, N., Yadav, M. K., Sharma, V., Sharma, A. K., Zghair, A. N., Dhama, K., Sharma, A., Kumar, V., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155100 · Cited by 69 · see citing works

Resveratrol and Related Stilbenoids, Nutraceutical/Dietary Complements with Health‐Promoting Actions: Industrial Production, Safety, and the Search for Mode of Action

Navarro, G., Martínez‐Pinilla, E., Ortiz, R., Noé, V., Ciudad, C. J., & Franco, R. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12359 · Cited by 63 · see citing works

Dietary Polyphenols and Gut Microbiota Cross-Talk: Molecular and Therapeutic Perspectives for Cardiometabolic Disease: A Narrative Review

Cano, R., Bermúdez, V., Galbán, N., Garrido, B., Santeliz, R., Gotera, M. P., Durán, P., Boscan, A., Carbonell, A., Durán‐Agüero, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169118 · Cited by 60 · see citing works

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Du, F., Huang, R., Lin, D., Wang, Y., Yang, X., Huang, X., Zheng, B., Chen, Z., Huang, Y., Wang, X., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.611323 · Cited by 58 · see citing works

A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases

Ezhilarasan, D., & Thangavelu, L. P. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9233650 · Cited by 63 · see citing works

Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review)

Anggreini, P., Kuncoro, H., Sumiwi, S. A., & Levita, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12922 · Cited by 58 · see citing works

Pomegranate juice prevents development of non‐alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation

Noori, M., Jafari, B., & Hekmatdoost, A. (2016) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8042 · Cited by 57 · see citing works

The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials

Akbari, M., Tamtaji, O. R., Lankarani, K. B., Tabrizi, R., Dadgostar, E., Haghighat, N., Kolahdooz, F., Ghaderi, A., Mansournia, M. A., & Asemi, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-1198-x · Cited by 57 · see citing works

Challenges in Analyzing the Biological Effects of Resveratrol

Erdogan, C. S., & Vang, O. (2016) · Nutrients · doi:10.3390/nu8060353 · Cited by 54 · see citing works

Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study

Eslamparast, T., Sharafkhah, M., Poustchi, H., Hashemian, M., Dawsey, S. M., Freedman, N. D., Boffetta, P., Abnet, C. C., Etemadi, A., Pourshams, A., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv365 · Cited by 53 · see citing works

Fine wine or sour grapes? A systematic review and meta-analysis of the impact of red wine polyphenols on vascular health

Weaver, S. R., Rendeiro, C., McGettrick, H. M., Philp, A., & Lucas, S. J. E. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02247-8 · Cited by 56 · see citing works

Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota

Godos, J., Romano, G. L., Gozzo, L., Laudani, S., Paladino, N., Azpíroz, I. D., López, N. M. M., Giampieri, F., Quiles, J. L., Battino, M. A., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1368949 · Cited by 51 · see citing works

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis

Jakubczyk, K., Skonieczna‐Żydecka, K., Kałduńska, J., Stachowska, E., Gutowska, I., & Janda, K. (2020) · Nutrients · doi:10.3390/nu12082435 · Cited by 49 · see citing works

An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Figueiredo, P. S., Inada, A. C., Fernandes, M. R., Arakaki, D. G., Freitas, K. D. C., Guimarães, R. D. C. A., do Nascimento, V. A., & Hiane, P. A. (2018) · Molecules · doi:10.3390/molecules23040877 · Cited by 48 · see citing works

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Perumpail, B. J., Li, A. A., Iqbal, U., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G. T., Kim, D., & Ahmed, A. (2018) · Diseases · doi:10.3390/diseases6030080 · Cited by 48 · see citing works

Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials

Zhang, C., Yuan, W., Fang, J., Wang, W., He, P., Lei, J., & Wang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161792 · Cited by 47 · see citing works

Dietary supplementation in patients with alcoholic liver disease: a review on current evidence

Ghorbani, Z., Hajizadeh, M., & Hekmatdoost, A. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60096-6 · Cited by 46 · see citing works

Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial

Darand, M., Darabi, Z., Yari, Z., Saadati, S., Hedayati, M., Khoncheh, A., Ahangar, B. H., Alavian, S. M., & Hekmatdoost, A. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.04.014 · Cited by 45 · see citing works

No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease

Farzin, L., Asghari, S., Rafraf, M., Jafarabadi, M. A., & Shirmohammadi, M. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000528 · Cited by 45 · see citing works

How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?

Silva, P., Sureda, A., Tur, J. A., Andreoletti, P., Cherkaoui‐Malki, M., & Latruffe, N. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1614176 · Cited by 44 · see citing works

The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Akbari, M., Tamtaji, O. R., Lankarani, K. B., Tabrizi, R., Dadgostar, E., Kolahdooz, F., Jamilian, M., Mirzaei, H., & Asemi, Z. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00324-6 · Cited by 43 · see citing works

Targeting Abdominal Obesity and Its Complications with Dietary Phytoestrogens

Kuryłowicz, A., Cakala, M., & Puzianowska‐Kuźnicka, M. (2020) · Nutrients · doi:10.3390/nu12020582 · Cited by 43 · see citing works

In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins

Kuryłowicz, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040572 · Cited by 43 · see citing works

Egg consumption and risk of non-alcoholic fatty liver disease

Mokhtari, Z., Poustchi, H., Eslamparast, T., & Hekmatdoost, A. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i10.503 · Cited by 42 · see citing works

No effect of resveratrol on VLDL‐TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease

Poulsen, M. K., Nellemann, B., Bibby, B. M., Stødkilde‐Jørgensen, H., Pedersen, S. B., Grønbæk, H., & Nielsen, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13409 · Cited by 41 · see citing works

Dietary Composition and Cardiovascular Risk: A Mediator or a Bystander?

Korakas, E., Dimitriadis, G., Raptis, A. E., & Lambadiari, V. (2018) · Nutrients · doi:10.3390/nu10121912 · Cited by 42 · see citing works

Beneficial effects of combined resveratrol and metformin therapy in treating diet‐induced insulin resistance

Frendo‐Cumbo, S., MacPherson, R. E. K., & Wright, D. C. (2016) · Physiological Reports · doi:10.14814/phy2.12877 · Cited by 39 · see citing works

Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis

García-Martínez, B. I., Ruíz-Ramos, M., Pedraza‐Chaverrí, J., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Antioxidants · doi:10.3390/antiox10010069 · Cited by 39 · see citing works

A Review on Rhubarb-Derived Substances as Modulators of Cardiovascular Risk Factors—A Special Emphasis on Anti-Obesity Action

Liudvytska, O., & Kołodziejczyk-Czepas, J. (2022) · Nutrients · doi:10.3390/nu14102053 · Cited by 38 · see citing works

Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling

Salami, M., Salami, R., Mafi, A., Aarabi, M. H., Vakili, O., & Asemi, Z. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467215666211217122523 · Cited by 37 · see citing works

Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review

Zhou, Q., Wang, Y., Han, X., Fu, S., Zhu, C., & Chen, Q. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.795980 · Cited by 37 · see citing works

The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease

Emamat, H., Foroughi, F., Eini‐Zinab, H., & Hekmatdoost, A. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0636-7 · Cited by 35 · see citing works

Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials

Guo, X., Li, J., Tang, J., & Li, D. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1349076 · Cited by 35 · see citing works

The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease

Emamat, H., Foroughi, F., Eini‐Zinab, H., Taghizadeh, M., Rismanchi, M., & Hekmatdoost, A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0248-4 · Cited by 34 · see citing works

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Amin‐Esmaeili, M., Rahimi‐Movaghar, A., Razaghi, E. M., Baghestani, A. R., & Jafari, S. (2012) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.806 · Cited by 33 · see citing works

Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial

Sangouni, A. A., Abdollahi, S., & Mozaffari–Khosravi, H. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02637-2 · Cited by 32 · see citing works

Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality

Stadler, J. T., & Marsche, G. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.761170 · Cited by 31 · see citing works

Preparation and Characterization of Resveratrol Loaded Pectin/Alginate Blend Gastro-Resistant Microparticles

Gartziandia, O., Lasa, A., Pedraz, J. L., Miranda, J., Portillo, M. P., Igartúa, M., & Hernández, R. M. (2018) · Molecules · doi:10.3390/molecules23081886 · Cited by 28 · see citing works

Cardioprotective effects of liposomal resveratrol in diabetic rats: unveiling antioxidant and anti-inflammatory benefits

Alanazi, A. Z., Alqinyah, M., Alhamed, A. S., Mohammed, H., Raish, M., Aljerian, K., Alsabhan, J. F., & Alhazzani, K. (2024) · Redox Report · doi:10.1080/13510002.2024.2416835 · Cited by 26 · see citing works

Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease

Simental‐Mendía, L. E., Gamboa‐Gómez, C. I., Guerrero‐Romero, F., Simental-Mendía, M. A., Sánchez‐García, A., & Rodríguez-Ramírez, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-64872-5_18 · Cited by 26 · see citing works

Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes

Trepiana, J., Krisa, S., Renouf, E., & Portillo, M. P. (2020) · Pharmaceuticals · doi:10.3390/ph13100285 · Cited by 25 · see citing works

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Ferro, Y., Pujia, R., Mazza, E., Lascala, L., Lodari, O., Maurotti, S., Pujia, A., & Montalcini, T. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03579-1 · Cited by 25 · see citing works

Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway

xu, X., Liu, Q., Li, J., Xiao, M., Gao, T., Zhang, X., Lu, G., Wang, J., Guo, Y., Wen, P., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.940406 · Cited by 25 · see citing works

Dark Sweet Cherry (Prunus avium) Supplementation Reduced Blood Pressure and Pro-Inflammatory Interferon Gamma (IFNγ) in Obese Adults without Affecting Lipid Profile, Glucose Levels and Liver Enzymes

Arbizu, S., Mertens‐Talcott, S. U., Talcott, S. T., & Noratto, G. D. (2023) · Nutrients · doi:10.3390/nu15030681 · Cited by 25 · see citing works

Current strategies for nonalcoholic fatty liver disease treatment (Review)

Sun, J., Jin, X., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5412 · Cited by 24 · see citing works

The effects of ginger supplementation on biomarkers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials

Askari, G., Aghajani, M., Salehi, M., Najafgholizadeh, A., Keshavarzpour, Z., Fadel, A., Venkatakrishnan, K., Salehi‐Sahlabadi, A., Hadi, A., & Pourmasoumi, M. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100364 · Cited by 26 · see citing works

Adipogenesis and therapeutic potentials of antiobesogenic phytochemicals: Insights from preclinical studies

Murugan, D. D., Balan, D., & Wong, P. (2021) · Phytotherapy Research · doi:10.1002/ptr.7205 · Cited by 24 · see citing works

Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials

Sergi, C. M., Chiu, B., Feulefack, J., Shen, F., & Chiu, B. (2020) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2020.95884 · Cited by 23 · see citing works

Effect of resveratrol supplementation on biomarkers associated with atherosclerosis in humans

Santana, T. M., Ogawa, L. Y., Rogero, M. M., Barroso, L. P., & de Castro, I. A. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101491 · Cited by 20 · see citing works

Effect of resveratrol and curcumin and the potential synergism on hypertension: A mini‐review of human and animal model studies

Hesarooeyeh, Z. G., Basham, A., Sheybani‐Arani, M., Abbaszadeh, M., Asl, A. S., Moghbeli, M., & Saburi, E. (2023) · Phytotherapy Research · doi:10.1002/ptr.8023 · Cited by 20 · see citing works

Current understanding and controversies on the clinical implications of fibroblast growth factor 21

Badakhshi, Y., & Jin, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1864278 · Cited by 20 · see citing works

Protective effect of resveratrol on mitochondrial biogenesis during hyperoxia-induced brain injury in neonatal pups

Yang, M., Shen, Y., Zhao, S., Zhang, R., Dong, W., & Lei, X. (2023) · BMC Neuroscience · doi:10.1186/s12868-023-00797-1 · Cited by 19 · see citing works

Plant-Derived Nutraceuticals Involved in Body Weight Control by Modulating Gene Expression

Vrânceanu, M., Hegheş, S. C., Cozma-Petruț, A. P., Banc, R., Stroia, C. M., Raischi, V., Miere, D., Popa, D., & Filip, L. A. (2023) · Plants · doi:10.3390/plants12122273 · Cited by 19 · see citing works

Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches

Cogorno, L., Formisano, E., Vignati, A., Prigione, A., Tramacere, A., Borgarelli, C., Sukkar, S. G., & Pisciotta, L. (2023) · Liver Research · doi:10.1016/j.livres.2023.08.005 · Cited by 19 · see citing works

Deoxyrhapontigenin, a Natural Stilbene Derivative Isolated From Rheum undulatum L. Induces Endoplasmic Reticulum Stress–Mediated Apoptosis in Human Breast Cancer Cells

Venkatesan, T., Jeong, M.-J., Choi, Y.-W., Park, E. J., El‐Desouky, S. K., & Kim, Y. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416636958 · Cited by 19 · see citing works

Mechanisms underlying the metabolic beneficial effect of curcumin intervention: Beyond anti-inflammation and anti-oxidative stress

Jin, T. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.11.002 · Cited by 19 · see citing works

Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease

Zhou, T., Jin, Z., Jiang, R., & Li, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1600439 · Cited by 19 · see citing works

Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State

Charytoniuk, T., Harasim‐Symbor, E., Polak, A., Drygalski, K., Berk, K., Chabowski, A., & Konstantynowicz-Nowicka, K. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666181224161255 · Cited by 17 · see citing works

The Clock‐NAD+‐Sirtuin connection in nonalcoholic fatty liver disease

Aggarwal, S., Trehanpati, N., Nagarajan, P., & Ramakrishna, G. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30772 · Cited by 17 · see citing works

No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease

Farzin, L., Asghari, S., Rafraf, M., Jafarabadi, M. A., & Shirmohammadi, M. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000528 · Cited by 45 · see citing works

Effects of Resveratrol Supplementation on Metabolic and Anthropometric Outcomes in Non-Alcoholic Fatty Liver Disease: An Umbrella Review and Updated Meta-Analysis

Molani‐Gol, R., Ebrahimi, A., Safari, S., & Rafraf, M. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr48116

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

Faghihzadeh, F., Adibi, P., Rafiei, R., & Hekmatdoost, A. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.09.005 · Cited by 345 · see citing works

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Chen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., Shu, F., Gao, Y., Yuan, L., Zhang, Q., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.015 · Cited by 319 · see citing works

Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis

Elgebaly, A. S., Radwan, I., Aboelnas, M. M., Ibrahim, H. H., Eltoomy, M., Atta, A. A., Mesalam, H. A., Sayed, A. A. E., & Othman, A. A. (2017) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.261.ely · Cited by 92 · see citing works